Sino Medical Sciences Technology In (688108) — Capital Reinvestment Ratio
Sino Medical Sciences Technology In (688108) has a Capital Reinvestment Ratio of 0.21x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥31.52 Million) in capital expenditures (CN¥6.63 Million). See Sino Medical Sciences Technology In (688108) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sino Medical Sciences Technology In Capital Reinvestment Ratio (2016–2024)
This chart tracks Sino Medical Sciences Technology In's Capital Reinvestment Ratio across 7 annual periods. Check Sino Medical Sciences Technology In investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Sino Medical Sciences Technology In (2016–2024)
Year-by-year Capital Reinvestment Ratio for Sino Medical Sciences Technology In from 2016 to 2024. For live market cap and broader valuation context, see 688108 market cap overview.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.53x | CN¥131.24 Million | CN¥70.02 Million | ▼ -55.2% |
| 2023 | 1.19x | CN¥56.84 Million | CN¥67.67 Million | ▼ -25.6% |
| 2020 | 1.60x | CN¥70.51 Million | CN¥112.78 Million | ▲ +22.2% |
| 2019 | 1.31x | CN¥137.61 Million | CN¥180.04 Million | ▲ +29.1% |
| 2018 | 1.01x | CN¥97.56 Million | CN¥98.87 Million | ▼ -6.5% |
| 2017 | 1.08x | CN¥70.32 Million | CN¥76.25 Million | ▲ +3.3% |
| 2016 | 1.05x | CN¥42.24 Million | CN¥44.32 Million | — |